Current Treatment of Peripheral T-cell Lymphoma

• Published in: Oncology (Williston Park, N.Y.) Vol. 36; no. 5; pp. 293 - 305
• Main Authors: Stuver, Robert, Epstein-Peterson, Zachary D, Johnson, William T, Khan, Niloufer, Lewis, Natasha, Moskowitz, Alison J, Sauter, Craig S, Horwitz, Steven
• Format: Journal Article
• Language: English
• Published: United States Intellisphere, LLC 01.05.2022; MultiMedia Healthcare Inc
• Subjects: Anthracyclines; Antigens; Antimitotic agents; Antineoplastic agents; B cells; Biopsy; Care and treatment; Cytotoxicity; Drug approval; Epstein-Barr virus; Genotype & phenotype; Leukemia; Lymphatic system; Lymphocytes; Lymphoma; Morphology; Non-Hodgkin's lymphomas; Remission (Medicine); Stem cells; T cells; Transplantation

The peripheral T-cell lymphomas (PTCLs) are a notoriously diverse family of non-Hodgkin lymphomas with generally aggressive biology. Clinical management is challenging given a largely inadequate literature base comprised of few randomized trials and heterogeneous observational reports. Herein, we pr...